Designed for in-stent restenosis:

The use of the BioStream™ PTCA catheter is indicated for patients with discrete lesions of the coronary arteries with a reference vessel diameter of 1.50 to 4.00 mm for the purpose of improving the coronary lumen diameter.
The BioStream™ PTCA catheter is indicated for the dilatation of the affected segments of a coronary artery or a coronary bypass in order to enhance myocardial perfusion. The BioStream paclitaxel eluting coronary balloon catheter is especially indicated for the treatment of coronary in-stent restenosis.

11239-000-EN – Rev.01
BioStream™
Main brochure

BioStream™
Ordering information

CAUTION: Please note that the following pages are exclusively reserved for Health Care Professionals in countries with applicable health authority product registrations. To the extent this site contains information intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions. Please contact your Biosensors representative for availability or the products and registration status.

The law restricts these devices to sale by or on the order of a physician. Prior to use, it is important to read the "Instructions for Use" supplied with these devices for indications, contraindications, suggested procedures, warnings, and precautions.

Biosensors’ interventional cardiology products, including BioMatrix Flex™, BioMatrix NeoFlex™, BioMatrix Alpha™, BioMatrix™, BioFreedom™, Chroma™, BioStream™, BMX-J®, BioPath™, Powerline™, are not available for sale in the United States and certain other countries.

BioMatrix, BioMatrix Flex, BioMatrix NeoFlex, BioMatrix Alpha, BioFreedom, Chroma, BioStream, BMX-J, BioPath, Juno, S-Stent, Powerline and Quadrature Link are trademarks or registered trademarks of Biosensors International Group, Ltd. All other cited trademarks are the property of their respective owners.